Skip to main content
Clinical Trials/CTRI/2021/07/034793
CTRI/2021/07/034793
Not yet recruiting
Phase 2

Determination of the median effective dose(ED50) of Levo-bupivacaine(0.5%)and Ropivacaine(0.5%)in unilateral spinal anaesthesia

Goverment Medical College baroda0 sites0 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Goverment Medical College baroda

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Elective unilateral limb(below knee) surgeries like amputation,debridement.
  • Height\-between 5feet and 6feet

Exclusion Criteria

  • Patients with absolute and relative contraindications to spinal anaesthesia (Patient refusal, Local skin infection, Vertebral column abnormalities, bleeding disorders, sever hypovolemia, thyroid disorders, cardiopulmonary disease, neuropathies ,severely altered mental status)
  • Patients with history of diabetes, renal or hepatic disease
  • Patients with allergy to local anaesthetics
  • Pregnant and lactating females
  • Morbid obesity(BMI \>29 kg/square metre)

Investigators

Sponsor
Goverment Medical College baroda

Similar Trials